Metabolic associated steatotic liver disease misses fewer high-risk patients than metabolic associated fatty liver disease
Saved in:
Main Authors: | Yu-Ming Cheng, Tsung-Han Hsieh, Shan-Wen Wang, Chia-Chi Wang, Jia-Horng Kao |
---|---|
Format: | Article |
Language: | English |
Published: |
Termedia Publishing House
2024-12-01
|
Series: | Clinical & Experimental Hepatology |
Subjects: | |
Online Access: | https://www.termedia.pl/Metabolic-associated-steatotic-liver-disease-misses-fewer-high-risk-patients-than-metabolic-associated-fatty-liver-disease,80,55233,1,1.html |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Steatotic Liver Disease: New Nomenclature and Its Localization in the Russian Federation
by: K. L. Raikhelson, et al.
Published: (2024-05-01) -
Global burden of metabolic dysfunction-associated steatotic liver disease, 2010 to 2021
by: Gong Feng, et al.
Published: (2025-03-01) -
Retinopathy in Metabolic Dysfunction-Associated Steatotic Liver Disease
by: Myrsini Orfanidou, et al.
Published: (2024-12-01) -
Liver macrophage activation: Relation with hepatic histopathological changes in patients with metabolic associated steatotic liver disease
by: Doaa H. Hegazy, et al.
Published: (2024-06-01) -
The impact of fasting on cardiovascular risk control in patients with metabolic dysfunction-associated steatotic liver disease
by: Anna E. Płatek, et al.
Published: (2023-09-01)